Selective Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+857
New +$184K 0.06% 126
2022
Q4
Sell
-1,305
Closed -$175K 128
2022
Q3
$175K Hold
1,305
0.08% 141
2022
Q2
$200K Hold
1,305
0.07% 143
2022
Q1
$212K Buy
1,305
+633
+94% +$92K 0.08% 130
2021
Q4
$91K Hold
672
0.04% 205
2021
Q3
$72K Hold
672
0.04% 219
2021
Q2
$76K Hold
672
0.06% 137
2021
Q1
$73K Hold
672
0.07% 102
2020
Q4
$72K Buy
672
+94
+16% +$9.03K 0.05% 91
2020
Q3
$51K Sell
578
-41
-7% -$3.86K 0.04% 99
2020
Q2
$61K Hold
619
0.05% 93
2020
Q1
$47K Hold
619
0.07% 63
2019
Q4
$55K Sell
619
-12
-2% -$996 0.07% 76
2019
Q3
$48K Buy
+631
New +$43.3K 0.07% 78

Other funds holding ABBV

Selective Wealth Management's ABBV Position: Q2 2026 in Review

Selective Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 857 shares worth $218K. The stake represents 0.06% of the portfolio and ranks #126 among its holdings. This is a return to the name: Selective Wealth Management previously reported a position in ABBV as recently as Q3 2022.

Selective Wealth Management first reported a position in ABBV in Q3 2019 and has held it in 14 quarters since. 1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Selective Wealth Management held 857 shares of AbbVie worth $218K as of Q2 2026.
  • AbbVie was a new Selective Wealth Management position in Q2 2026.
  • AbbVie made up 0.06% of Selective Wealth Management's portfolio in Q2 2026, its #126 holding.
  • Selective Wealth Management first reported a position in AbbVie in Q3 2019 and has held it in 14 quarters since.
  • 1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Selective Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.